Skip to content
HowShorted

HERON THERAPEUTICS, INC. short interest in 2021

In 2021, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 19.54% of shares outstanding on 15 Jan 2021 to 35.96% on 31 Dec 2021, a change of +16.42 percentage points. The year's high was 35.96% on 31 Dec 2021 and its low 19.54% on 15 Jan 2021, averaging 25.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.03 days on 15 Sep 2021. Full history: HERON THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for HERON THERAPEUTICS, INC. in 2021

2021 in figures

Start of year
19.54% (15 Jan 2021)
End of year
35.96% (31 Dec 2021)
Change
+16.42 pp
High
35.96% (31 Dec 2021)
Low
19.54% (15 Jan 2021)
Average
25.32%
Highest days to cover
30.03 (15 Sep 2021)
SEC filings marked
9

Every report in 2021

HERON THERAPEUTICS, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202119.54%20.70results (8-K)
29 Jan 202121.07%17.36
12 Feb 202121.57%25.16
26 Feb 202122.05%25.4910-K filed, results (8-K)
15 Mar 202122.48%27.25
31 Mar 202123.09%17.00
15 Apr 202123.43%25.16
30 Apr 202122.98%19.87
14 May 202120.80%9.5910-Q filed, results (8-K)
28 May 202123.25%10.85
15 Jun 202123.62%19.33
30 Jun 202123.29%15.89
15 Jul 202123.81%15.61
30 Jul 202125.21%22.08
13 Aug 202125.23%17.3610-Q filed, results (8-K)
31 Aug 202126.71%21.99
15 Sep 202125.87%30.03
30 Sep 202126.39%19.41
15 Oct 202127.74%21.38
29 Oct 202129.17%16.92
15 Nov 202130.20%16.7810-Q filed, results (8-K)
30 Nov 202130.84%17.64
15 Dec 202133.33%10.35
31 Dec 202135.96%21.42

See also: HERON THERAPEUTICS, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.